A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
about
Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinomaSynthetic high-density lipoprotein-like nanoparticles as cancer therapyLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaHigh-Density Lipoproteins: Nature's Multifunctional NanoparticlesEvaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platformNanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair.High-density lipoproteins for the systemic delivery of short interfering RNA.Chitosan-based intelligent theragnosis nanocomposites enable pH-sensitive drug release with MR-guided imaging for cancer therapy.Design of a multicomponent peptide-woven nanocomplex for delivery of siRNA.Synthetic high-density lipoprotein-like nanoparticles for cancer therapyHigh-Density Lipoproteins for Therapeutic Delivery Systems.Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse ModelCholesterol-Containing Nuclease-Resistant siRNA Accumulates in Tumors in a Carrier-free Mode and Silences MDR1 Gene.Lipid-based nanoparticles in the systemic delivery of siRNA.Learning from biology: synthetic lipoproteins for drug delivery.Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems.Properties of Native High-Density Lipoproteins Inspire Synthesis of Actively Targeted In Vivo siRNA Delivery Vehicles.Pokemon promotes the invasiveness of hepatocellular carcinoma by enhancing MEF2D transcription.Lipoproteins and lipoprotein mimetics for imaging and drug delivery.Endocytosis in gene therapy with non-viral vectors.miR-125/Pokemon auto-circuit contributes to the progression of hepatocellular carcinoma.Delivery strategies and potential targets for siRNA in major cancer typesPokemon and MEF2D co-operationally promote invasion of hepatocellular carcinoma.Arachidonic acid-modified lovastatin discoidal reconstituted high density lipoprotein markedly decreases the drug leakage during the remodeling behaviors induced by lecithin cholesterol acyltransferase.Lipid-Drug Conjugate for Enhancing Drug Delivery.Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma.Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins.Tethering Interleukin-22 to Apolipoprotein A-I Ameliorates Mice from Acetaminophen-induced Liver Injury.Targeted Delivery of siRNA Therapeutics to Malignant Tumors.RNA interference-based therapy and its delivery systems.Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates.In Vivo RNAi Efficacy of Palmitic Acid-Conjugated Dicer-Substrate siRNA in a Subcutaneous Tumor Mouse Model.Suppression of Remodeling Behaviors with Arachidonic Acid Modification for Enhanced in vivo Antiatherogenic Efficacies of Lovastatin-loaded Discoidal Recombinant High Density Lipoprotein.Improved method for synthesis of low molecular weight protamine-siRNA conjugate.Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug deliveryReconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
P2860
Q26823523-DA00EAF0-8DE1-4853-A9D8-F72E9DB9B7E0Q26825009-0B48AAB0-7191-4110-BDB5-FAE70C856B6FQ28068437-D897A6E1-5E75-4887-948A-CA38BBB66409Q28077290-C461C89D-7A24-466A-8EC6-52AB9ECC5797Q28541661-5B647553-5B82-4F3A-B0C1-FA5FD85A66B2Q30601810-F89BDA75-4B20-4BA0-AB29-CD3507C57AF1Q33786171-60A60F1B-62D1-478F-9398-3F4E3368477FQ34481521-45C6F194-EC40-48CE-8A72-0D68BA1BD904Q35112531-47C4133C-4CF0-486C-87BB-D94A8DDBCAA8Q36264073-E6C8588A-002B-4937-8709-90D4A1CDCB57Q36781321-E073BEF9-7BE7-44C2-B871-AD0818B1D8EAQ36792563-049BAB63-3EF4-4902-BF96-B76BF4287ED1Q37718210-AFEAB064-B45E-49FE-89A9-8B4E0336F527Q38172634-9AA04CFE-AD81-4B0C-9AE3-AD4A9C54EB57Q38262882-09DF185D-0FDF-4FF9-9964-E8DE7237AD92Q38271422-5291E994-4530-4C0C-A504-2CA9CB11DC05Q38674708-358118A2-163C-4362-A0A6-28DB7655E58DQ38800576-6C15FA46-4227-48ED-8B95-7B467073533FQ38822339-DD53924F-1A10-4A74-A325-8E7906482ED2Q38824421-18E83A05-BDA1-4735-8BA5-9285511FBA6AQ38847751-28797A40-D219-46CC-863C-9A05902879E5Q38853191-B0EC2D41-5DB1-451C-B556-E05365C1DBF7Q38854324-D8E4AC77-1D91-4287-B4A2-B69B445A7D56Q39032031-F10FDC65-5D2F-421A-BB27-4940B1D3E888Q39083391-B1C167AB-8012-48EF-A606-DE66F900C93AQ39086982-D921DBEC-AB1F-4E14-8A65-856EDC0CDAC8Q44304922-C054878D-D6FB-46FB-B5F4-5EADB9C7FFD6Q45874775-70D7C10F-7029-48AA-B7BC-5CFE34AF415FQ47152520-E43B9F97-8154-49DC-A718-57258C22A5D2Q47565462-E5FD2C21-F77C-414F-BEB0-213AA3F1E2EAQ50131778-15B5B496-8C3C-4D5C-B3B0-EA9278A5E5E2Q50234594-7504D53E-B32B-44EE-8FFD-9C882793DA5EQ53479332-AC5448FD-42ED-4693-BC1E-AB40051947AAQ54957884-E5A86599-F1FA-4FA2-A4A9-C2AE0B0F83F1Q57377122-6B978682-54CE-4A56-9B00-2A9398B6DC56Q58122191-38F175CC-A507-413E-A681-9FECC423E70C
P2860
A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A biomimetic nanovector-mediat ...... livery for tumor gene therapy.
@en
A biomimetic nanovector-mediat ...... livery for tumor gene therapy.
@nl
type
label
A biomimetic nanovector-mediat ...... livery for tumor gene therapy.
@en
A biomimetic nanovector-mediat ...... livery for tumor gene therapy.
@nl
prefLabel
A biomimetic nanovector-mediat ...... livery for tumor gene therapy.
@en
A biomimetic nanovector-mediat ...... livery for tumor gene therapy.
@nl
P2093
P1433
P1476
A biomimetic nanovector-mediat ...... livery for tumor gene therapy.
@en
P2093
Congyan Liu
Jianping Zhou
Meiqing Feng
Qiang Zhang
Ruoning Wang
Xuefang Ding
P304
P356
10.1016/J.BIOMATERIALS.2012.08.057
P577
2012-09-12T00:00:00Z